DS
Desconocido
NADINE: Nanosystems for the early Diagnosis of Neurodegenerative diseases
DIAGNOSWISS SA
participó en un
FP7:
Medical diagnosis is currently undergoing a major revolution due to the fast discovery of molecular biomarkers, and the development of multi...
Financiado
Financiado
TRANSBIOBC: Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction
DIAGNOSWISS SA
participó en un
FP7:
Currently, clinical diagnosis and monitoring of bladder cancer (BC) relies on invasive, highly costly cystoscopy. Additionally, due to high...
Financiado
Financiado
* No se disponen de datos de la empresa actual.